NYSE - Nasdaq Real Time Price • USD
Warby Parker Inc. (WRBY)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 6:43 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 0.07 | 0.05 | 0.18 | 0.28 |
| Low Estimate | 0.06 | 0.03 | 0.14 | 0.23 |
| High Estimate | 0.08 | 0.06 | 0.2 | 0.3 |
| Year Ago EPS | 0.06 | 0.04 | 0.1 | 0.18 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | 196.36M | 186.99M | 755.13M | 851.01M |
| Low Estimate | 195.75M | 182.1M | 750.4M | 833.3M |
| High Estimate | 197M | 197M | 757M | 868.1M |
| Year Ago Sales | 171.97M | 166.09M | 669.76M | 755.13M |
| Sales Growth (year/est) | 14.20% | 12.60% | 12.70% | 12.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.04 | 0.02 | 0.01 | 0.01 |
| EPS Actual | 0.06 | 0.04 | 0.01 | -0.01 |
| Difference | 0.02 | 0.02 | 0 | -0.02 |
| Surprise % | 50.00% | 100.00% | 0.00% | -200.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.07 | 0.05 | 0.18 | 0.28 |
| 7 Days Ago | 0.07 | 0.05 | 0.18 | 0.28 |
| 30 Days Ago | 0.07 | 0.04 | 0.18 | 0.27 |
| 60 Days Ago | 0.07 | 0.04 | 0.19 | 0.28 |
| 90 Days Ago | 0.08 | 0.06 | 0.19 | 0.28 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | WRBY | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 16.70% | -- | -- | 0.80% |
| Next Qtr. | 25.00% | -- | -- | 9.60% |
| Current Year | 80.00% | -- | -- | 4.50% |
| Next Year | 55.60% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Telsey Advisory Group: Outperform to Outperform | 2/28/2024 |
| Reiterates | Telsey Advisory Group: Outperform to Outperform | 2/21/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/24/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/9/2023 |
| Upgrade | BTIG: Neutral to Buy | 10/12/2023 |
| Upgrade | Evercore ISI Group: In-Line to Outperform | 10/3/2023 |
Related Tickers
ANGO AngioDynamics, Inc.
6.12
-3.32%
TFX Teleflex Incorporated
207.38
-0.44%
OSUR OraSure Technologies, Inc.
5.25
0.00%
ICUI ICU Medical, Inc.
96.90
+1.06%
COO The Cooper Companies, Inc.
90.41
+0.61%
RGEN Repligen Corporation
157.06
-2.44%
EMBC Embecta Corp.
10.35
+1.07%
XRAY DENTSPLY SIRONA Inc.
30.44
+0.26%
BLCO Bausch + Lomb Corporation
14.32
+0.07%
ANIK Anika Therapeutics, Inc.
25.43
-1.01%